Incidence and clinical significance of bacterial and fungal contamination of the preservation solution in liver transplantation

Transplant Infectious Disease

Volumn 13, Issue 1, 2011, Pages 84-88

  Audet, M ^a   Piardi, T ^a   Panaro, F ^a   Ghislotti, E ^a   Gheza, F ^a   Cag, M ^a   Jarzembowski, T M ^b   Flicoteaux, H ^a   Wolf, P ^a   Cinqualbre, J ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b United Hospital System   (United States)

Author keywords

Immunosuppressant; Liver transplantation; Microbial prophylaxis; Preservation solution

Indexed keywords

CELSIOR; UNIVERSITY OF WISCONSIN SOLUTION;

ACINETOBACTER BAUMANNII; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIUM CONTAMINATION; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; BREVIBACTERIUM; CANDIDA ALBICANS; CLOSTRIDIUM DIFFICILE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORYNEBACTERIUM; ENTEROBACTER CLOACAE; ENTEROCOCCUS; FUNGAL CONTAMINATION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN TISSUE; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS; LIVER; LIVER PERFUSION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MICROANALYSIS; NONHUMAN; OBSERVATIONAL STUDY; ORGAN DONOR; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROPIONIBACTERIUM; PSEUDOMONAS AERUGINOSA; SACCHAROMYCES; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS;

BACTERIAL INFECTIONS; DRUG CONTAMINATION; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; MYCOSES; ORGAN PRESERVATION SOLUTIONS; TISSUE DONORS;

EID: 79551671080     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00529.x     Document Type: Article

References (11)

1. Wakelin SJ, Casey J, Robertson A, et al. The incidence and importance of bacterial contaminants of cadaveric renal perfusion fluid. Transpl Int 2005; 17 (11): 680-686.
2. Sharma AK, Smith G, Smith D, et al. Clinical outcome of cadaveric renal allografts contaminated before transplantation. Transpl Int 2005; 18 (7): 824-827.
3. Van der Vliet JA, Tidow G, Kootstra G, et al. Transplantation of contaminated organs. Br J Surg 1980; 67 (8): 596-598.
4. Van der Werf WJ, D'Alessandro AM, Hoffmann RM, Knechtle SJ. Procurement, preservation, and transport of cadaver kidneys. Surg Clin North Am 1998; 78 (1): 41-54.
5. Buchholz B, Zastrow F, Lison AE, Ritzerfeld W. The perfusate culture-bacteriologic monitoring of kidney grafts. Urologe A 1985; 24 (1): 36-38.
6. Ibrahim T, Stafford H, Esler CN, Power RA. Cadaveric allograft microbiology. Int Orthop 2004; 28 (5): 315-318.
7. Keating MR, Guerrero MA, Daly RC, Walker RC, Davies SF. Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest 1996; 109 (4): 1119-1124.
8. González-Segura C, Pascual M, García Huete L, et al. Donors with positive blood culture: could they transmit infections to the recipients? Transplant Proc 2005; 37 (9): 3664-3666.
9. Gottesdiener KM. Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med 1989; 110 (12): 1001-1016.
10. Cerutti E, Stratta C, Romagnoli R, et al. Bacterial- and fungal-positive cultures in organ donors: clinical impact in liver transplantation. Liver Transpl 2006; 12 (8): 1253-1259.
11. Zibari GB, Lipka J, Zizzi H, et al. The use of contaminated donor organs in transplantation. Clin Transplant 2000; 14 (4 Part 2): 397-400.